Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The price of Elanco Animal Health Inc (NYSE: ELAN) closed at $13.46 in the last session, up 0.30% from day before closing price of $13.42. In other words, the price has increased by $0.30 from its previous closing price. On the day, 5.66 million shares were traded.
Ratios:
We take a closer look at ELAN’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 13.73 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 19.26. For the most recent quarter (mrq), Quick Ratio is recorded 1.46 and its Current Ratio is at 2.71. In the meantime, Its Debt-to-Equity ratio is 0.69 whereas as Long-Term Debt/Eq ratio is at 0.68.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, UBS on December 09, 2024, initiated with a Buy rating and assigned the stock a target price of $18.
On December 02, 2024, Leerink Partners started tracking the stock assigning a Market Perform rating and target price of $14.
Morgan Stanley Downgraded its Overweight to Equal-Weight on September 19, 2024, whereas the target price for the stock was revised from $17 to $15.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 07 ’25 when Kurzius Lawrence Erik bought 10,000 shares for $10.90 per share. The transaction valued at 109,000 led to the insider holds 101,459 shares of the business.
Kurzius Lawrence Erik bought 10,000 shares of ELAN for $102,000 on Mar 11 ’25. The Director now owns 111,459 shares after completing the transaction at $10.20 per share. On Mar 05 ’25, another insider, HOOVER R DAVID, who serves as the Director of the company, bought 25,000 shares for $10.90 each. As a result, the insider paid 272,558 and bolstered with 210,000 shares of the company.
Valuation Measures:
As of this moment, Elanco’s Price-to-Earnings (P/E) ratio for their current fiscal year is 17.96, and their Forward P/E ratio for the next fiscal year is 14.05. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.97. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.51 while its Price-to-Book (P/B) ratio in mrq is 1.05.
Stock Price History:
Over the past 52 weeks, ELAN has reached a high of $18.80, while it has fallen to a 52-week low of $8.02. The 50-Day Moving Average of the stock is 24.86%, while the 200-Day Moving Average is calculated to be 9.40%.
Shares Statistics:
A total of 496.46M shares are outstanding, with a floating share count of 491.95M. Insiders hold about 0.95% of the company’s shares, while institutions hold 100.92% stake in the company.
